ArticleScientific reports2018

Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle.

Woojung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.